EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS177-11236 
Organism
Homo sapiens 
Tissue/cell
SK-N-SH_RA 
Coordinate
chr2:739480-741290 
Target genes
Number: 1             
NameEnsembl ID
AC116609.2ENSG00000223751
TF binding sites/motifs
Number: 29             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF14MA0740.1chr2:740080-740094GAGGGGGCGTGGCC-7.52
KLF14MA0740.1chr2:740332-740346GAGGGGGCGTGGCC-7.52
KLF14MA0740.1chr2:740647-740661GAGGGGGCGTGGCC-7.52
KLF14MA0740.1chr2:740773-740787GAGGGGGCGTGGCC-7.52
KLF16MA0741.1chr2:740397-740408GGGGGCGGGGC-6.02
KLF16MA0741.1chr2:740838-740849GGGGGCGGGGC-6.02
KLF16MA0741.1chr2:740082-740093GGGGGCGTGGC-6.62
KLF16MA0741.1chr2:740334-740345GGGGGCGTGGC-6.62
KLF16MA0741.1chr2:740649-740660GGGGGCGTGGC-6.62
KLF16MA0741.1chr2:740775-740786GGGGGCGTGGC-6.62
KLF5MA0599.1chr2:740398-740408GGGGCGGGGC-6.02
KLF5MA0599.1chr2:740839-740849GGGGCGGGGC-6.02
SP1MA0079.4chr2:740081-740096AGGGGGCGTGGCCCA-6.12
SP1MA0079.4chr2:740333-740348AGGGGGCGTGGCCCA-6.12
SP1MA0079.4chr2:740648-740663AGGGGGCGTGGCCCA-6.12
SP1MA0079.4chr2:740774-740789AGGGGGCGTGGCCCA-6.12
SP3MA0746.2chr2:740081-740094AGGGGGCGTGGCC-6.82
SP3MA0746.2chr2:740333-740346AGGGGGCGTGGCC-6.82
SP3MA0746.2chr2:740648-740661AGGGGGCGTGGCC-6.82
SP3MA0746.2chr2:740774-740787AGGGGGCGTGGCC-6.82
SP4MA0685.1chr2:740394-740411GGAGGGGGCGGGGCCCA-6.05
SP4MA0685.1chr2:740079-740096CGAGGGGGCGTGGCCCA-6.17
SP4MA0685.1chr2:740331-740348CGAGGGGGCGTGGCCCA-6.17
SP4MA0685.1chr2:740646-740663CGAGGGGGCGTGGCCCA-6.17
SP4MA0685.1chr2:740772-740789CGAGGGGGCGTGGCCCA-6.17
SP8MA0747.1chr2:740081-740093AGGGGGCGTGGC-6.92
SP8MA0747.1chr2:740333-740345AGGGGGCGTGGC-6.92
SP8MA0747.1chr2:740648-740660AGGGGGCGTGGC-6.92
SP8MA0747.1chr2:740774-740786AGGGGGCGTGGC-6.92
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_33276chr2:739763-741094H1
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr2739492739565
Enhancer Sequence
CTTAGTGCCT GTGACATACA CGTGCGTCAT TGCTGTGCAG GAGGCAGGGG AATGGGGGGC 60
CAGGGAGTGG GGAGCTGGAG TCACAGGACC CAAAGTGACA GGTGCATGGA GGAATGAGCT 120
TTTTATTTAT TCATTACTTT CATGTCCCCA TGCAGCAGTC ACAGAAAAAA AAAACATGTA 180
AGTAAGAAAA ATTTTGAATG TAAACTAGAG AGTAGTTAGT GGCCCTATTG TAGACTAAAT 240
AATGGCCTCC TACAGATACC CATGTTGCAG TCGGCGGAGC CTGTGAATGT CCCTTCCACG 300
GACCCTGCAG GTGGGCTCAG CGAAGGGCCT GAAGATGGGA GCTGACTGTC CTGGGGGGTC 360
CACTGGAATC GCAGAGGGCC TCGTCAGAGG GAGGCAGAGA TCGGAGTGAA CCAGCCGCAA 420
GCCAAGCACT GCGGGCACCA GGAAAGCTGG AGAGGCAGCG AGGATCTTGG GTTAGAGCCT 480
AGTGAGGGGG CGCGGCCCAG CCAGGAAGGC AGCCAGGATC TTCCCTCAGA GCCTAGCGAG 540
GGGGCGCGGC CCAGCCAGGA GAGCTGGAGA GGCAGCGAGG ATGTTCCCTC AGAGCCTGGC 600
GAGGGGGCGT GGCCCAGCCA GGAGGGCGGG AGAGGCAGTG AAGATCTTCC CTCAGAGCCT 660
GGCGAGGGGG CGCGGCCCAG CCAGGAGAGC TGGAGAGGCC CGGAGGATCT TCCCTCAGAG 720
CCTAGCGAGG GAGCGCGGCC CAGCCAGGAG AGCTGGAGAG GCAGCCAGGA TCTTCCCTCA 780
GAGCCTGGCG AGTGAGGGCG GCCCAGCCAG GAGAGCTGGA GAGGCAGCGA GGATGTTCCC 840
TCAGAGCCTG GCGAGGGGGC GTGGCCCAGC CAGGAGGGCG GGAGAGGCAG TGAAGATCTT 900
CCCTCAGAGC CTGGGGAGGG GGCGGGGCCC AGCCAGGAGA GCTGGAGAGG CAGCCAGGAT 960
CTTCCCTCAG AGCCTGGCGA GGGGGCGCGG CCCAGCCAGG AGAGCTGGAG AGGCAGCGAG 1020
GATCTTCCCT CAGAGCCTAT CTAGGGGGCG CGGCCCAGCC AGGAGAGCTG GAGAGGCAGC 1080
GAAGATCTTC CGTTAGAGCC CAGCGAGGGG GTGTGGCCCA GCCAGGAGGG CTGGAGAGGC 1140
AGCGAGGATC TTCCCTAAGA GCGTGGCGAG GGGGCGTGGC CCAGCCAGGA GAGCTGGAGA 1200
GGCAGCGAGG ATCTTCCCTC AGAGCCTGGC GAGGGGGCGC GGCCCAGCCA GGAGAGCTGG 1260
AGAGGCAGCG AAGATCTTCC GTTAGAGCCC AGCGAGGGGG CGTGGCCCAG CCAGGAGGGC 1320
TGGAGTGGCA GCCAGGATCT TCCCTCAGAG CCTGGCGAGG GGGCGGGGCC CAGCCAGGAG 1380
AGCTGGAGAG GCAGCCAGGA TCTTCCCTTA GAGCCCGGCG AGCGGGCGCG GCCCTGCCTA 1440
CACCCCGACT TCATCCCAGT GAGGAGGACG TCGGACTTCT GGCCTCCAGA GCTGTGAGAA 1500
AATACATTTG AGATGTTCAA GCTGCCCAAT GTCTGGTCAT TTGTTACAAA AGATATGGAA 1560
AATCAACGCA CCAGTAACTG GAGAAAATTG ATCACGACTG AAAGGCAGTG GGCAAAACGT 1620
ACTGTTGTAG GTCAGCCCAG ACCAGAAACT GTAAGTCTAT CAAACAGGCG GAGAAAAGCG 1680
GCCACCGTTT TATTCCTCAA GAATTGCACA GTGTTTATTT AAGTCAGCAA CCCTGTGGAG 1740
CAGATTTAAA TTTTATACAA TTTCTAGACA TACGGCATGC ACCCACACGT GTATAATCAT 1800
CATGCATGCA 1810